MedPath

Xtenda

Brand Name: Xtenda

Generic Name: Ceftriaxone (as Sodium)

Active
Registration Number

DR-XY40686

Dosage Form

Powder for Injection

Issuance Date

February 1, 2022

Expiry Date

February 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1g
PackagingBP Type I colorless glass vial

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftriaxone (as Sodium)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform